Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chloride channels are a diverse group of anion-selective ion channels that facilitate the passive movement of chloride ions (Cl⁻) and, in some cases, other anions across cellular membranes. They play essential roles in regulating neuronal excitability, muscle contraction (skeletal, cardiac, and smooth), cell volume homeostasis, transepithelial salt transport, and acidification of intracellular organelles. Dysfunction or mutation in specific chloride channel genes leads to diseases such as myotonia congenita (ClC‐1 mutations) or cystic fibrosis (CFTR mutations). These proteins are targets for drug development aimed at modulating their activity—either enhancing function where deficient or inhibiting overactive pathways.
Enhancing function where deficient or inhibiting overactive pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chloride Channels (None).